Rank 94 • MedTech & Devices
Moximed
Develops the MISHA Joint System, an implantable shock absorber for knee osteoarthritis.
Visit website- Signal Score
- 79.8
- Total raised
- $170M
- Stage
- Series C
- Founded
- 2006
- Headquarters
- Fremont, USA
- Region
- North America
Their signal
Provides an innovative, joint-preserving implant designed for active osteoarthritis patients who are too young for total knee replacement, filling a major clinical treatment gap.
Signal Score 79.8editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.